Login to Your Account

Financings Roundup

Proteostasis Raises $45M for Protein Homeostasis Disorders

By Donna Young

Tuesday, August 26, 2008
Newly formed Cambridge, Mass.-based Proteostasis Therapeutics Inc. has raised $45 million in a Series A financing to develop therapies, which the firm has dubbed proteostasis regulators, to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies, such as Alzheimer's disease, emphysema, Type II diabetes and Huntington's disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription